急性小剂量肼苯哒嗪诱发的狼疮综合征（HILS）。
Acute low-dose hydralazine induced lupus syndrome (HILS).
作者信息
Chisholm J C
出版信息
J Natl Med Assoc. 1981 Mar;73(3):278-80.
Abstract
A case of acute hydralazine induced lupus syndrome is described. No case has previously been described in which a small daily dose and a small accumulation dose have evoked this syndrome in such a short period of time. A pertinent and selective review of this syndrome is presented. The need for awareness of this syndrome manifesting in a patient exposed to small doses of hydralazine for short periods of time is emphasized.
摘要
本文描述了一例急性肼屈嗪诱发的狼疮综合征病例。此前尚无小剂量每日给药及小累积剂量在如此短时间内诱发该综合征的病例报道。本文对该综合征进行了相关且有选择性的综述。强调了对于短期接触小剂量肼屈嗪的患者出现该综合征的认识需求。
相似文献
1
Acute low-dose hydralazine induced lupus syndrome (HILS).
J Natl Med Assoc. 1981 Mar;73(3):278-80.
2
The lupus syndrome induced by hydralazine: a common complication with low dose treatment.
Br Med J (Clin Res Ed). 1984 Aug 18;289(6442):410-2. doi: 10.1136/bmj.289.6442.410.
3
Hydralazine and lupus nephritis.
Clin Nephrol. 1984 Nov;22(5):230-8.
4
Hydralazine, antinuclear antibodies, and the lupus syndrome.
Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):936-9. doi: 10.1136/bmj.284.6320.936.
5
Hydralazine-induced lupus syndrome.
Ala J Med Sci. 1984 Oct;21(4):427-30.
6
Hydralazine induced lupus and Sweet's syndrome. Report and review of the literature.
J Rheumatol. 1990 May;17(5):682-4.
7
Sweet syndrome associated with hydralazine-induced lupus erythematosus.
Cutis. 2012 Mar;89(3):121-4.
8
Hydralazine induced lupus syndrome with eye disease.
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):675. doi: 10.1136/bmj.290.6469.675.
9
Hydralazine--is there a safe dose?
Med J Aust. 1985 Mar 18;142(6):337. doi: 10.5694/j.1326-5377.1985.tb113404.x.
10
A case of hypertension and systemic lupus erythematosus.
Proc Rudolf Virchow Med Soc City N Y. 1970;28:157-8.
引用本文的文献
1
An intriguing case of anemia and renal failure.
Proc (Bayl Univ Med Cent). 2019 Jan 24;32(1):78-79. doi: 10.1080/08998280.2018.1540824. eCollection 2019 Jan.
2
Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis.
Case Rep Pulmonol. 2017;2017:2650142. doi: 10.1155/2017/2650142. Epub 2017 Aug 8.
本文引用的文献
1
Multiple reactions to antihypertensive agents during treatment of malignant hypertension.
Ann Intern Med. 1962 Sep;57:441-50. doi: 10.7326/0003-4819-57-3-441.
2
Abnormalities of circulating cells and proteins in hydralazine-treated patients without toxic symptoms.
Am J Med Sci. 1962 Jul;244:44-53. doi: 10.1097/00000441-196207000-00006.
3
Syndrome simulating collagen disease caused by hydralazine (Apresoline).
J Am Med Assoc. 1954 Feb 20;154(8):670-3. doi: 10.1001/jama.1954.02940420032009.
4
Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus.
Medicine (Baltimore). 1967 Jan;46(1):1-33. doi: 10.1097/00005792-196701000-00001.
5
Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.
J Immunol. 1966 Mar;96(3):464-71.
6
Genetic variations in the acetylation of isoniazid and other drugs.
Ann N Y Acad Sci. 1968 Jul 31;151(2):723-33. doi: 10.1111/j.1749-6632.1968.tb48255.x.
7
Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.
J Lab Clin Med. 1970 Jul;76(1):114-25.
8
Drug-induced lupus syndromes.
Mayo Clin Proc. 1969 Sep;44(9):664-81.
9
Hydralazine elimination in man.
Clin Pharmacol Ther. 1973 Nov-Dec;14(6):970-7. doi: 10.1002/cpt1973146970.
10
Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
Am J Med. 1973 Jan;54(1):58-72. doi: 10.1016/0002-9343(73)90084-3.
Zotero 插件